153 related articles for article (PubMed ID: 1271893)
21. Target cell - substratum interaction. I. Effect of primed lymphocytes on a rat mammary adenocarcinoma tumor cell line.
David GS; Wiglesworgh CM
Immunol Commun; 1978; 7(3):337-52. PubMed ID: 77840
[TBL] [Abstract][Full Text] [Related]
22. Immunological investigation and immunotherapy in patients operated on for breast carcinoma.
Reynier J; Villet R; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM
Int Surg; 1982; 67(1):17-24. PubMed ID: 7095998
[TBL] [Abstract][Full Text] [Related]
23. Mediation of immune responses to tumor antigens by immune RNA.
Pilch YH
Prog Exp Tumor Res; 1980; 25():163-77. PubMed ID: 6986630
[No Abstract] [Full Text] [Related]
24. Horizons in tumor immunology. A seminar.
Wilson RE; Alexander P; Rosenberg SA; Simmons RL
Arch Surg; 1974 Jul; 109(1):17-29. PubMed ID: 4834133
[No Abstract] [Full Text] [Related]
25. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
26. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
[TBL] [Abstract][Full Text] [Related]
27. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
Greager JA; Baldwin RW
Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
[No Abstract] [Full Text] [Related]
28. Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient.
Hersh EM; Mavligit GM; Gutterman JU
Med Clin North Am; 1976 May; 60(3):623-39. PubMed ID: 775211
[No Abstract] [Full Text] [Related]
29. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
Int J Cancer; 1974 Mar; 13(3):389-403. PubMed ID: 4822108
[No Abstract] [Full Text] [Related]
30. [Immune surveillance in neoplasms].
Schneeweiss U
Z Exp Chir; 1974; 7(4):204-15. PubMed ID: 4440030
[No Abstract] [Full Text] [Related]
31. [Monoclonal antibodies and cancer].
López González JS; Selman Lama M
Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
[No Abstract] [Full Text] [Related]
32. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
33. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
34. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
35. Antigenic differences among B16 melanoma variants selected for their differing abilities to metastasize: a possible mechanism for effective adjuvant immunotherapy.
Steele G; Wang BS; Ghavamzadah G; Fallon M; Richie J; Wilson RE; Mannick JA
J Surg Oncol; 1980; 15(1):71-83. PubMed ID: 6158632
[No Abstract] [Full Text] [Related]
36. Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring.
Ramming KP; deKernion JB
Ann Surg; 1977 Oct; 186(4):459-67. PubMed ID: 907390
[TBL] [Abstract][Full Text] [Related]
37. Clinical aspects of cancer immunity.
Moore GE
Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
[No Abstract] [Full Text] [Related]
38. Tumor-specific cellular immunity.
Cohen AM; Burdick JF; Ketcham AS
J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
[No Abstract] [Full Text] [Related]
39. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
40. [Immunotherapy of malignant tumors in man].
Govalle VI
Vopr Onkol; 1976; 22(3):99-109. PubMed ID: 779262
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]